Jama Pitman - 12 Dec 2023 Form 4 Insider Report for Deciphera Pharmaceuticals, Inc.

Role: Title: SVP, Regulatory, Quality, & Portfolio Management
Signature: /s/ Jeffrey M. Held, Attorney-in-Fact
Issuer symbol: N/A
Transactions as of: 12 Dec 2023
Net transactions value: -$25,540
Form type: 4
Filing time: 14 Dec 2023, 16:05:13 UTC
Previous filing: 31 Oct 2023
Next filing: 18 Jan 2024
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	DCPH	Common Stock	Award		+5,576	+12%		53,859	12 Dec 2023	Direct	F1
transaction	DCPH	Common Stock	Sale	$25,540	-1,662	-3.1%	$15.37	52,197	13 Dec 2023	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	On February 15, 2023, the Reporting Person was granted restricted stock units ("RSUs"), which vest upon the satisfaction of three performance criteria. On December 12, 2023, the Issuer's Compensation Committee confirmed that performance criteria one had been met, resulting in the vesting of 5,576 RSUs.
F2	This sale was to cover tax liabilities in the vesting of RSUs.

Remarks:

Title: SVP, Regulatory, Quality, & Portfolio Management